Pathstone Holdings’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$798K Sell
5,225
-3,377
-39% -$563K ﹤0.01% 1631
2026
Q1
$1.8M Buy
8,602
+729
+9% +$183K 0.01% 1083
2025
Q4
$2.24M Sell
7,873
-1,535
-16% -$480K 0.01% 955
2025
Q3
$2.9M Buy
9,408
+2,397
+34% +$751K 0.01% 826
2025
Q2
$2.2M Buy
7,011
+265
+4% +$76.5K 0.01% 942
2025
Q1
$1.77M Buy
6,746
+738
+12% +$200K 0.01% 1049
2024
Q4
$1.57M Buy
6,008
+160
+3% +$40.3K 0.01% 1117
2024
Q3
$1.36M Sell
5,848
-284
-5% -$58.3K 0.01% 1202
2024
Q2
$1.24M Buy
6,132
+2,629
+75% +$474K 0.01% 1197
2024
Q1
$600K Buy
3,503
+1,080
+45% +$201K ﹤0.01% 1590
2023
Q4
$526K Buy
+2,423
New +$416K ﹤0.01% 1479

Other funds holding PODD

Pathstone Holdings's PODD Position: Q2 2026 in Review

Pathstone Holdings reduced its Insulet (PODD) stake by 39% in Q2 2026, selling an estimated $563K and leaving 5,225 shares worth $798K. The position accounts for ﹤0.01% of the portfolio, ranked #1631.

Pathstone Holdings first reported a position in PODD in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.9M in Q3 2025. 722 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Pathstone Holdings held 5,225 shares of Insulet worth $798K as of Q2 2026.
  • Pathstone Holdings sold 3,377 Insulet shares in Q2 2026, an estimated $563K.
  • Insulet made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #1631 holding.
  • Pathstone Holdings first reported a position in Insulet in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's Insulet position peaked at $2.9M in Q3 2025.
  • 722 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.